New legislation in California would aim to curb opioid addiction; increasing number of generics are causing medicines to be more affordable; healthcarey company focused on serving low-income urban residents receives first round funding.
A California legislator has introduced new bills that hope to tackle opioid addiction by restricting access to the drugs. According to the Los Angeles Times, the 3 measures would build on the state database’s ability to track prescriptions and provide a clearer and more up-to-date picture of prescriptions. For instance, one of the measures would link the California database to other states in order to track doctor shopping across state lines.The availability of more generic alternatives and slowing price inflation are causing prescription medicines to become more affordable, according to CVS Health and Walgreens Boots Alliance. The companies said their pharmacy revenues are taking a hit from those changes, reported The Wall Street Journal. However, the companies both expect profits to increase since generics have a higher margin than brand-name drugs.A healthcare company focused on serving low-income urban residents has received $20.8 million in first-round funding from investors that include J Mario Molina, MD, and a new investment firm formed by Andy Slavitt, the former acting administrator for CMS under President Barack Obama. According to Reuters, Cityblock’s goal is trying to make it easier for low-income individuals in urban areas to get personalized care, such as preventive visits and accessing appropriate social services, in order to avoid unnecessary emergency department visits and prevent larger healthcare crises.
SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps
April 15th 2025Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing the need for strategies to increase their uptake in primary care.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Significant Disease Burden and Management Issues in Chronic Spontaneous Urticaria
April 15th 2025Patients with chronic spontaneous urticaria experienced a long delay in diagnosis, a substantial impact on their quality of life, and often received inadequate treatment, highlighting the need for better management and understanding of the condition.
Read More
Lifestyle Interventions, Statins, Among Keys to Mitigating CVD Risk in MASLD/MASH
April 15th 2025A recent review highlights the gaps in clinical guidelines and treatment approaches for metabolic dysfunction-associated steatohepatitis (MASH) and looks ahead to the future promise of glucagon-like peptide 1 (GLP-1) receptor agonists for liver conditions.
Read More